126864 multi building dry chem fire suppression system

Active Awarded Last action

Contract number
75N91026F00025
Awardee
Awarding agency
Obligated
$880,989

Award facts

Opportunity
  • NCINCIFOSO260078 Solicitation number
Contract value 100% obligated
$880,989.00 Current and potential, with all options
Completion date 7% complete
Current and potential, with all options
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 2, 2026, for a multi-building dry chemical fire suppression system with a ceiling value of $880,989.00 and an ultimate completion date of August 21, 2028.

Place of performance is Frederick, Maryland. The order is priced on a cost-plus-fixed-fee basis.

Quick answers

Who was awarded contract 75N91026F00025?

75N91026F00025 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 2, 2026.

How much is contract 75N91026F00025 worth?

The government has obligated $880,989 on 75N91026F00025.

Is contract 75N91026F00025 an order under another contract?

Yes. 75N91026F00025 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91026F00025 competed?

The extent of competition for 75N91026F00025 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award